Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
39.73
+0.13 (0.32%)
Oct 9, 2026, 10:50 AM EDT - Market open
HRMY Market Cap
HRMY has a market cap or net worth of $2.31 billion as of October 9, 2026. It is the 6,167th most valuable company in the world and the 1,674th biggest in the United States. Its market cap has increased by 51.40% in one year.
Market Cap
2.31B
Enterprise Value
1.81B
1-Year Change
51.40%
Global Rank
Country Rank
#1,674 United States
Category
ChartMarket Cap Chart
Since the IPO on August 19, 2020, HRMY's market cap has increased from $461.03M to $2.31B, an increase of 401.79%. That is a compound annual growth rate of 30.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.31B | 7.34% |
| Dec 31, 2025 | 2.16B | 9.82% |
| Dec 31, 2024 | 1.96B | 3.73% |
| Dec 29, 2023 | 1.89B | -42.12% |
| Dec 30, 2022 | 3.27B | 31.09% |
| Dec 31, 2021 | 2.49B | 21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 19, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beam Therapeutics | 2.51B |
| Recursion Pharmaceuticals | 2.45B |
| Celldex Therapeutics | 2.43B |
| Disc Medicine | 2.42B |
| Nurix Therapeutics | 2.34B |
| ADMA Biologics | 2.30B |
| SELLAS Life Sciences Group | 2.29B |
| Immunome | 2.26B |